Persistent hypoglycemia and hyperinsulinemia: caution in using glucagon.
Thoma
M E
ME
Glauser
J
J
Genuth
S
S
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects*; D000437:Alcoholism / Q000150:complications; D001262:Atenolol / Q000009:adverse effects*; D005934:Glucagon / Q000009:adverse effects*; D005905:Glyburide / Q000009:adverse effects*; D006801:Humans; D006946:Hyperinsulinism / Q000150:complications; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D007004:Hypoglycemic Agents; D001262:Atenolol; D005934:Glucagon; D005905:Glyburide